Med Ad News caught up with Sharon Callahan, the new CEO of CDM, and Robin Shapiro, who moved into the position of CEO of TBWA\WorldHealth, to talk with them about the changes at their agencies and what it’s like taking on new roles a time when COVID-19 has literally changed everything about the way that everyone works.
The Mylan board of directors appointed Robert J. Coury, previously chairman of the Mylan board, to the position of executive chairman of Mylan.
Yuyu Pharma, a global pharmaceutical company based in Korea, selected Robert Wonsang Yu as president and CEO.
PTC Therapeutics Inc. appointed Matthew Klein, M.D., as chief development officer and Eric Pauwels as chief business officer.
The board of directors of BioSpecifics Technologies Corp. appointed Joseph Truitt as interim CEO. He will also serve on the company’s board of directors. Truitt succeeds J. Kevin Buchi, who served as CEO since October 2019, and has departed the company. “We are delighted to have Joe on board and believe he will play a […]
Tatsuya Kaihara was tapped as corporate officer and head of North America business of Santen Pharmaceutical Co. Ltd.
Q BioMed Inc., a commercial-stage biotech company, appointed Geoff Fatzinger as the global head of regulatory affairs.
EVERSANA a leading independent provider of global commercial services to the life sciences industry, appointed Ed Cox to executive VP, strategic alliances and global head of the company’s new digital medicine practice area.
Bolt Biotherapeutics Inc., a private clinical-stage biotechnology company, tapped Edith Perez, M.D., as chief medical officer.
ORIC Pharmaceuticals Inc., a privately held clinical-stage oncology company, appointed Christian V. Kuhlen, M.D., general counsel.